Virionics Corporation

Category: Drugs & Pharmaceuticals

our mission is to develop and commercialize virus-like particles (VLPs), a groundbreaking, new medical technology that harnesses the power of the immune system to treat and prevent a wide variety of diseases.

Virionics is a private company headquartered in Scottsdale, Arizona, and was founded to commercialize the next-generation of vaccines and immunotherapies based on its proprietary Virus-Like Particle (VLP) technology.

The Company focuses on the clinical & regulatory development and the commercialization of products for the treatment and prevention of viral diseases, including human papillomavirus (HPV), the leading cause of cervical cancer, hepatitis C virus (HCV), and human immunodeficiency virus (HIV).